Stay updated with breaking news from Proprietary Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: CureVac / Key word: Study results CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong...
EcoGraf ASX:EGR ASX Release / 26 March 2024 Product Qualification Facility Commissioning Commenced 'State of the Art' Facility utilising EcoGraf HFfree™ Proprietary Technology to Provide High Purity Battery Anode Material to the Global Battery... - Veroeffentlicht am 26.03.2024
Whenever chaos engulfs a proprietary technology relied on by millions, the default knee-jerk reaction from many seems to be: "." This scenario became all too familiar throughout 2023, as established technologies relied on by millions hit a chaos curve, making people realize how beholden they are to a proprietary platform they have little control over. The OpenAI fiasco in November, where the ChatGPT hit-maker temporarily lost its co-founders, including CEO Sam Altman, created a whirlwind five days of chaos culminating in Altman returning to the OpenAI hotseat.
“One cannot get the consistent compounding like with Asian Paints, but in the case of Tega or say Grindwell Norton in our Rising Giants portfolio, these sorts of companies, you get the upside when the capex cycle is switched on. But you do not get hammered on the downside when the global economy softens up.”
Biotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call Transcript November 14, 2023 Operator: Good afternoon, and welcome to Biotricity’s Second Quarter Fiscal 2024 Financial Results and Business Update Conference Call. Today’s conference is being recorded. And at this time, I would like to turn the conference over to Debra Chen with Investor Relations. Please go ahead, […]